4.6 Article

Synthesis of Novel N4-Hydrocytidine Analogs as Potential Anti-SARS-CoV-2 Agents

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Immunology

A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic

Chris R. Triggle et al.

Summary: Although significant progress has been made in understanding the mechanics of virus transmission and the immune response, there are still unanswered questions about reinfection, susceptibility of the elderly, and whether asymptomatic children contribute to transmission. Uncertainties remain regarding the pathophysiology of COVID-19, variations in clinical presentations, and the phenomenon of long haulers. Currently, there are no highly effective drugs for treating COVID-19, with trials of hydroxychloroquine proving unsuccessful. Remdesivir has shown some success in aiding recovery of severely ill patients, but does not reduce mortality like dexamethasone. However, vaccine development has seen substantial advancements, with several vaccines being approved for use globally.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

β-D-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells

Shuntai Zhou et al.

Summary: Mutagenic ribonucleosides can serve as broad-spectrum antiviral agents, but may pose risks to the host due to their host mutagenic activity in addition to antiviral activity.

JOURNAL OF INFECTIOUS DISEASES (2021)

Review Biochemistry & Molecular Biology

The origins of SARS-CoV-2: A critical review

Edward C. Holmes et al.

Summary: This article critically reviews the current scientific evidence to help clarify the origin of SARS-CoV-2. Recent debate has centered around two competing ideas: a laboratory escape scenario and zoonotic emergence.
Review Biochemistry & Molecular Biology

Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19

Joyce van de Leemput et al.

Summary: This article summarizes the progress in studying SARS-CoV-2 proteins so far, analyzing the impact of self-acting and host-interacting proteins on virus replication and host system disruption, while introducing drugs targeting the virus and virus-interacting host proteins, providing valuable research directions for future coronavirus outbreaks.

MOLECULAR AND CELLULAR BIOLOGY (2021)

Article Microbiology

Repurposing Nucleoside Analogs for Human Coronaviruses

Keivan Zandi et al.

Summary: Novel nucleoside analogs with antiviral activity against CoV-2 and HCoV-OC43 were identified, while sofosbuvir was found to have no antiviral effect against CoV-2.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Multidisciplinary Sciences

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

David E. Gordon et al.

NATURE (2020)

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

News Item Medicine, General & Internal

Covid-19: Remdesivir has little or no impact on survival, WHO trial shows

Owen Dyer

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Chemistry, Medicinal

Structure-activity relationships of 2′-modified-4′-selenoarabinofuranosyl-pyrimidines as anticancer agents

Jin-Hee Kim et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)

Article Biochemistry & Molecular Biology

Synthesis and biological properties of pyrimidine 4'-fluoronucleosides and 4'-fluorouridine 5'-O-triphosphate

M. A. Ivanov et al.

RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY (2010)

Article Biochemistry & Molecular Biology

N-4-hydroxycytosine dioxolane nucleosides and their activity against hepatitis B virus

JF Du et al.

NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2005)